Cite
The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits.
MLA
Mohanta, Sarajo Kumar, et al. “The Dawn Has Come for New Therapeutics to Treat Atherosclerosis: Targeting Neuroimmune Cardiovascular Interfaces in Artery Brain Circuits.” Clinical & Translational Medicine, vol. 12, no. 9, Sept. 2022, pp. 1–7. EBSCOhost, https://doi.org/10.1002/ctm2.1040.
APA
Mohanta, S. K., Weber, C., Yin, C., & Habenicht, A. J. R. (2022). The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits. Clinical & Translational Medicine, 12(9), 1–7. https://doi.org/10.1002/ctm2.1040
Chicago
Mohanta, Sarajo Kumar, Christian Weber, Changjun Yin, and Andreas J. R. Habenicht. 2022. “The Dawn Has Come for New Therapeutics to Treat Atherosclerosis: Targeting Neuroimmune Cardiovascular Interfaces in Artery Brain Circuits.” Clinical & Translational Medicine 12 (9): 1–7. doi:10.1002/ctm2.1040.